MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle

  1. Brian A Hodge
  2. Xiping Zhang
  3. Miguel A Gutierrez-Monreal
  4. Yi Cao
  5. David W Hammers
  6. Zizhen Yao
  7. Christopher A Wolff
  8. Ping Du
  9. Denise Kemler
  10. Andrew R Judge
  11. Karyn A Esser  Is a corresponding author
  1. University of Florida, United States
  2. Genentech Inc, United States
  3. Allen Institute for Brain Science, United States

Abstract

In the present study we show that the master myogenic regulatory factor, MYOD1, is a positive modulator of molecular clock amplitude and functions with the core clock factors for expression of clock-controlled genes in skeletal muscle. We demonstrate that MYOD1 directly regulates the expression and circadian amplitude of the positive core clock factor Bmal1. We identify a non-canonical E-box element in Bmal1 and demonstrate that is required for full MYOD1-responsiveness. Bimolecular fluorescence complementation assays demonstrate that MYOD1 colocalizes with both BMAL1 and CLOCK throughout myonuclei. We demonstrate that MYOD1 and BMAL1:CLOCK work in a synergistic fashion through a tandem E-box to regulate the expression and amplitude of the muscle specific clock-controlled gene, Titin-cap (Tcap). In conclusion, these findings reveal mechanistic roles for the muscle specific transcription factor MYOD1 in the regulation of molecular clock amplitude as well as synergistic regulation of clock-controlled genes in skeletal muscle.

Data availability

ChIP seq data for muscle with MyoD is deposited in GEO under accession code GSE122082.

The following data sets were generated

Article and author information

Author details

  1. Brian A Hodge

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  2. Xiping Zhang

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  3. Miguel A Gutierrez-Monreal

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  4. Yi Cao

    Department of Bioinformatics and Computational Biology, Genentech Inc, South San Francisco, United States
    Competing interests
    Yi Cao, Is affiliated with Genentech Inc.. The author has no other competing interests to declare.
  5. David W Hammers

    Department of Pharmacology and Therapeutics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  6. Zizhen Yao

    Cell Types Program, Allen Institute for Brain Science, Seattle, United States
    Competing interests
    No competing interests declared.
  7. Christopher A Wolff

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  8. Ping Du

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  9. Denise Kemler

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  10. Andrew R Judge

    Department of Physical Therapy, University of Florida, Gainesville, United States
    Competing interests
    No competing interests declared.
  11. Karyn A Esser

    Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
    For correspondence
    kaesser@ufl.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5791-1441

Funding

National Institutes of Health (R01AR066082)

  • Karyn A Esser

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (IACUC Study 201809136) of the University of Florida.

Copyright

© 2019, Hodge et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,838
    views
  • 535
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Brian A Hodge
  2. Xiping Zhang
  3. Miguel A Gutierrez-Monreal
  4. Yi Cao
  5. David W Hammers
  6. Zizhen Yao
  7. Christopher A Wolff
  8. Ping Du
  9. Denise Kemler
  10. Andrew R Judge
  11. Karyn A Esser
(2019)
MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle
eLife 8:e43017.
https://doi.org/10.7554/eLife.43017

Share this article

https://doi.org/10.7554/eLife.43017

Further reading

    1. Cell Biology
    Fabian Link, Sisco Jung ... Brooke Morriswood
    Research Article

    The actin cytoskeleton is a ubiquitous feature of eukaryotic cells, yet its complexity varies across different taxa. In the parasitic protist Trypanosoma brucei, a rudimentary actomyosin system consisting of one actin gene and two myosin genes has been retained despite significant investment in the microtubule cytoskeleton. The functions of this highly simplified actomyosin system remain unclear, but appear to centre on the endomembrane system. Here, advanced light and electron microscopy imaging techniques, together with biochemical and biophysical assays, were used to explore the relationship between the actomyosin and endomembrane systems. The class I myosin (TbMyo1) had a large cytosolic pool and its ability to translocate actin filaments in vitro was shown here for the first time. TbMyo1 exhibited strong association with the endosomal system and was additionally found on glycosomes. At the endosomal membranes, TbMyo1 colocalised with markers for early and late endosomes (TbRab5A and TbRab7, respectively), but not with the marker associated with recycling endosomes (TbRab11). Actin and myosin were simultaneously visualised for the first time in trypanosomes using an anti-actin chromobody. Disruption of the actomyosin system using the actin-depolymerising drug latrunculin A resulted in a delocalisation of both the actin chromobody signal and an endosomal marker, and was accompanied by a specific loss of endosomal structure. This suggests that the actomyosin system is required for maintaining endosomal integrity in T. brucei.

    1. Cell Biology
    Georgia Maria Sagia, Xenia Georgiou ... Sofia Dimou
    Research Article Updated

    Membrane proteins are sorted to the plasma membrane via Golgi-dependent trafficking. However, our recent studies challenged the essentiality of Golgi in the biogenesis of specific transporters. Here, we investigate the trafficking mechanisms of membrane proteins by following the localization of the polarized R-SNARE SynA versus the non-polarized transporter UapA, synchronously co-expressed in wild-type or isogenic genetic backgrounds repressible for conventional cargo secretion. In wild-type, the two cargoes dynamically label distinct secretory compartments, highlighted by the finding that, unlike SynA, UapA does not colocalize with the late-Golgi. In line with early partitioning into distinct secretory carriers, the two cargoes collapse in distinct ER-Exit Sites (ERES) in a sec31ts background. Trafficking via distinct cargo-specific carriers is further supported by showing that repression of proteins essential for conventional cargo secretion does not affect UapA trafficking, while blocking SynA secretion. Overall, this work establishes the existence of distinct, cargo-dependent, trafficking mechanisms, initiating at ERES and being differentially dependent on Golgi and SNARE interactions.